Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001209191-19-046922
Filing Date
2019-08-20
Accepted
2019-08-20 21:11:13
Documents
1
Period of Report
2019-08-05

Document Format Files

Seq Description Document Type Size
1 FORM 3 SUBMISSION doc3.html 3  
1 FORM 3 SUBMISSION doc3.xml 3 3259
  Complete submission text file 0001209191-19-046922.txt   4612
Mailing Address 965 ATLANTIC AVENUE SUITE 101 ALAMEDA CA 94501
Business Address 965 ATLANTIC AVENUE SUITE 101 ALAMEDA CA 94501 510-671-8370
AgeX Therapeutics, Inc. (Issuer) CIK: 0001708599 (see all company filings)

EIN.: 821436829 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 965 ATLANTIC AVENUE, SUITE 101 ALAMEDA CA 94501
Business Address
MAY MICHAEL H (Reporting) CIK: 0001785908 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-38519 | Film No.: 191041141